Search for: "ACTAVIS" Results 741 - 760 of 1,006
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Feb 2012, 12:56 am
However, it was the generic manufacturers Actavis and PLIVA that have been trying to avoid lawsuits. [read post]
10 Jan 2012, 7:55 am by Dan Hargrove
From Bloomberg:Units of Actavis Group Hf agreed to pay $118.6 million to resolve claims that they caused the U.S. and four state governments to overpay for drugs. [read post]
8 Jan 2012, 9:00 pm by Laurent Teyssèdre
La société Actavis commercialise un médicament comprenant le valsartan en association avec de l'hydrochlorothiazide. [read post]
3 Jan 2012, 3:56 pm by eithurburn@getnicklaw.com
  As part of the settlement, both Actavis and Texas waive their right to appeal. [read post]
26 Dec 2011, 12:37 pm by Steve McConnell
Actavis Totowa, LLC, 2009 WL 1082026 (N.D. [read post]
16 Dec 2011, 9:15 pm by Patent Docs
Conference highlights include: • Benefit from industry perspectives throughout the day with IBC faculty of experienced corporate counsel; • Hear the tips and traps of current tactics for maximising patent life cycles and data exclusivity; • Gain an excellent understanding of the latest SPC position including a consideration of the judgments of key decisions including Novartis v Actavis, Medeva and Georgetown University; • Analyse the practical implications on everyday… [read post]
15 Dec 2011, 2:43 am
The recall affects lots of the Actavis Fentanyl Transdermal System 25 mcg/hour C-II patches at the wholesale and retail level. [read post]
9 Dec 2011, 2:44 am by Lawrence B. Ebert
., Obviousness Approaches of the EPO and The English Courts ), discussing Actavis v Novartis [2010] EWCA Civ 82, 17th February 2010 . [read post]
7 Dec 2011, 6:38 am by Medicare Set Aside Services
In November 2011, the FDA approved generic equivalents of the brand name product Kadian®, which is an extended-release morphine product manufactured by Actavis Elizabeth LLC. [read post]
2 Nov 2011, 2:00 am by Marie Louise
French courts give conflicting answers in preliminary injunction proceedings: Actavis v Novartis (EPLAW) Vytorin (Ezetimibe and Simvastatin) – US: Schering  files patent infringement complaint against Actavis in response to Para IV certification (Patent Docs) [read post]
10 Oct 2011, 12:31 am
 "We can now confirm that the deadline to submit comments on Case C- 442/11 Novartis AG v Actavis UK Limited is 14 October 2011" writes the UK Intellectual Property Office, which adds "If you would like to comment on this case please e-mail policy@ipo.gsi.gov.uk before 14 October 2011". [read post]
28 Sep 2011, 1:56 am by Marie Louise
(Kluwer Patent Blog) Gabitril (Tiagabine) – US: Cephalon files suits against Sun Pharma. in New Jersey and Michigan in response to Para IV certification (Patent Docs) Glivec (Imatinib) – India: Novartis Glivec patent case: preliminary objection (Spicy IP) Lovenox (Enoxaparin) – US: Momenta files patent infringement complaint against Amphastar in response to impending launch of generic Lovenox (Patent Docs) Lumigan (Bimatoprost) – US: Validity of Allergan Lumigan patents… [read post]
21 Sep 2011, 2:36 am by Marie Louise
Novartis AG v Actavis UK Limited (The SPC blog) (The SPC blog) Europe: Note on recent ECJ Memantine and Galantamine rulings (The SPC blog) US: Federal Circuit denies petition for rehearing in AMP v. [read post]
20 Sep 2011, 6:35 am by Bexis
Actavis, Inc., ___ F.3d ___, 2011 WL 3659409 (5th Cir. [read post]
16 Aug 2011, 11:35 pm by Marie Louise
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
14 Aug 2011, 9:59 pm by Patent Docs
Actavis South Atlantic LLC et al. 1:11-cv-00704; filed August 10, 2011 in the District Court of Delaware • Plaintiffs: Avanir Pharmaceuticals Inc.; Avanir Holding Company; Center for Neurologic Study • Defendants:... [read post]